<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-11-06 23:50:12Vemurafenib Metastasis Protein kinase inhibitor Cancer Raf kinase Skin cancer Ipilimumab Medicine Melanoma BRAF |
|
| First Page | Document Content | |
|---|---|---|
Date: 2014-11-06 23:50:12Vemurafenib Metastasis Protein kinase inhibitor Cancer Raf kinase Skin cancer Ipilimumab Medicine Melanoma BRAF |
|
1207: Final Decision Analytical Protocol (DAP) to guide the assessment of BRAF V600 mutation testing in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment